Regeneron Antibody Drug Appears Effective At Preventing Covid-19
Faizan Hashmi Published April 12, 2021 | 07:52 PM
US biotech firm Regeneron and its Swiss partner Roche unveiled promising clinical trial results Monday indicating that an antibody treatment used to treat Covid-19 patients also helps prevent infections
Zurich, (APP - UrduPoint / Pakistan Point News - 12th Apr, 2021 ) :US biotech firm Regeneron and its Swiss partner Roche unveiled promising clinical trial results Monday indicating that an antibody treatment used to treat Covid-19 patients also helps prevent infections.
The results of the Phase 3 trial showed that the combination of the antibodies casirivimab and imdevimab dramatically reduced the risk of symptomatic infection among people living with Covid-19 patients, Roche said in a statement.
The trial entailed injecting 1,505 people not infected with the SARS-CoV-2 virus but living in households with people carrying the virus with the Regeneron antibody cocktail or a placebo.
The trial, which was conducted in cooperation with the National Institute of Allergy and Infectious Diseases, showed that those who received the antibody cocktail saw their risk of symptomatic infection reduced by 81 percent, the companies said.
It also indicated that those treated with casirivimab and imdevimab who did experience symptomatic infection on average saw their symptoms clear within one week -- far faster than the three-week average for those who received the placebo.
In a separate part of the study, 204 people who had recently tested positive for Covid-19 but showed no symptoms received either a dose of the antibody cocktail or a placebo.
Those who received the cocktail saw their risk of developing symptoms reduced by 31 percent compared to the placebo group, the companies said.
"Today's data confirm the potential dual value of casirivimab and imdevimab to reduce household Covid-19 infections and to decrease the disease burden in those who do become infected, when given as a subcutaneous option," Levi Garraway, Roche's chief medical officer said in a statement.
"Although vaccinations are increasing globally, there remains a critical unmet need worldwide to prevent infections and provide immediate protection from Covid-19 between close contacts," he said.
Regeneron president and chief scientist George Yancopoulos agreed, pointing out that in the United States alone, 60,000 people are being diagnosed with Covid-19 every day.
The antibody cocktail "may help provide immediate protection to unvaccinated people who are exposed to the virus", he said in a statement, adding that it could also potentially "provide ongoing protection for immunocompromised patients who may not respond well to vaccines".
Regeneron said it would present the data to the US food and Drug Administration and request it clear the Covid antibody cocktail for use as a preventative treatment.
The companies said they would share the new data with health regulators worldwide.
Related Topics
Recent Stories
Israel carries out attack inside Iran, report US media
Saudi Assistant Minister of Defence calls on army chief
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 19 April 2024
Today Gold Rate in Pakistan 19 April 2024
Rock-solid Ruud racks up season-leading win in Barcelona
At UN, Iran says it will make Israel 'regret' reprisals
G7 hears calls for 'critical' Ukraine aid
EU seeks to leverage might to confront China, US challenge
5 Customs officials martyred as their vehicle ambushed by terrorists in D I Khan
Pak-New Zealand match called off due to rain
NHA restores traffic on roads affected by recent rains in Balochistan
China to fully support Pakistan's efforts against terrorism: Ambassador Jiang
More Stories From World
-
Taylor Swift's 'The Tortured Poets Department' drops
3 minutes ago -
'Ancient Roman' solar roof tiles power Pompeii villa
3 minutes ago -
Ukraine says eight killed in overnight Russian strikes
1 hour ago -
Meta releases beefed-up AI models
1 hour ago -
Ukraine says downed Russian long-range strategic bomber
1 hour ago -
Israel carries out attack inside Iran, report US media
1 hour ago
-
IAEA says 'no damage to Iran's nuclear sites'
2 hours ago -
The flamenco dress, an Andalusian classic evolving with fashion
2 hours ago -
Taylor Swift's 'The Tortured Poets Department' drops
2 hours ago -
Tokyo's Nikkei drops over 1,000 points, most in 3 years
2 hours ago -
Alternate jurors to be confirmed at Trump trial
2 hours ago -
Ambassador Munir Akram discusses issues on UN agenda with Iran's top diplomat
2 hours ago